Literature DB >> 22351188

Fetal alcohol spectrum disorders-- implications for child neurology, part 1: prenatal exposure and dosimetry.

Ashley Paintner1, Andrew D Williams, Larry Burd.   

Abstract

In the United States, approximately 80 000 women consume ethanol through all 3 trimesters of pregnancy each year. In this article, we review prevalence rates of prenatal alcohol exposure in the United States and discuss the mechanisms of prenatal alcohol exposure and placental-umbilical effects. Cigarette smoking and delayed prenatal care are often associated with prenatal alcohol exposure. In addition, increased risk for postnatal adversity is common, including maternal depression, foster care placement, and developmental delay. In part 2, we review prevalence rates and the diagnostic criteria for fetal alcohol spectrum disorder and the implications for child neurologists. We discuss management strategies and the importance of a long-term management plan and anticipatory management to prevent the development of secondary disabilities in fetal alcohol spectrum disorders. Child neurologists play a key role in diagnosis and the development of appropriate intervention programs for affected children and their families.

Entities:  

Mesh:

Year:  2012        PMID: 22351188     DOI: 10.1177/0883073811428376

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice.

Authors:  Shivakumar Subbanna; Delphine Psychoyos; Shan Xie; Balapal S Basavarajappa
Journal:  J Neurochem       Date:  2015-04-30       Impact factor: 5.372

2.  Ethnic Enclaves and Pregnancy and Behavior Outcomes Among Asian/Pacific Islanders in the USA.

Authors:  Andrew D Williams; Lynne C Messer; Jenna Kanner; Sandie Ha; Katherine L Grantz; Pauline Mendola
Journal:  J Racial Ethn Health Disparities       Date:  2019-11-14

3.  Sustained action of developmental ethanol exposure on the cortisol response to stress in zebrafish larvae and adults.

Authors:  Matteo Baiamonte; Caroline H Brennan; Gavin P Vinson
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

4.  Renal dysfunction in fetal alcohol syndrome: a potential contributor on developmental disabilities of offspring.

Authors:  Farahnak Assadi
Journal:  J Renal Inj Prev       Date:  2014-12-01

5.  Sustained Effects of Developmental Exposure to Ethanol on Zebrafish Anxiety-Like Behaviour.

Authors:  Matteo Baiamonte; Matthew O Parker; Gavin P Vinson; Caroline H Brennan
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

6.  An interaction of a NR3C1 polymorphism and antenatal solar activity impacts both hippocampus volume and neuroticism in adulthood.

Authors:  Christian Montag; Markus Eichner; Sebastian Markett; Carlos M Quesada; Jan-Christoph Schoene-Bake; Martin Melchers; Thomas Plieger; Bernd Weber; Martin Reuter
Journal:  Front Hum Neurosci       Date:  2013-06-05       Impact factor: 3.169

7.  Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada.

Authors:  Svetlana Popova; Shannon Lange; Larry Burd; Karen Urbanoski; Jürgen Rehm
Journal:  BMC Public Health       Date:  2013-06-11       Impact factor: 3.295

8.  FASD and ADHD: Are they related and How?

Authors:  Larry Burd
Journal:  BMC Psychiatry       Date:  2016-09-22       Impact factor: 3.630

Review 9.  Fetal alcohol-spectrum disorders: identifying at-risk mothers.

Authors:  Annika C Montag
Journal:  Int J Womens Health       Date:  2016-07-21

10.  The utility of zebrafish to study the mechanisms by which ethanol affects social behavior and anxiety during early brain development.

Authors:  Matthew O Parker; Leonette V Annan; Alexandros H Kanellopoulos; Alistair J Brock; Fraser J Combe; Matteo Baiamonte; Muy-Teck Teh; Caroline H Brennan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-03-30       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.